These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

297 related items for PubMed ID: 29869087

  • 1. Prospective study of the effect of topical application of Mitomycin C in refractory pediatric caustic esophageal strictures.
    Ghobrial CM, Eskander AE.
    Surg Endosc; 2018 Dec; 32(12):4932-4938. PubMed ID: 29869087
    [Abstract] [Full Text] [Related]

  • 2. Topical mitomycin C can effectively alleviate dysphagia in children with long-segment caustic esophageal strictures.
    El-Asmar KM, Hassan MA, Abdelkader HM, Hamza AF.
    Dis Esophagus; 2015 Jul; 28(5):422-7. PubMed ID: 24708423
    [Abstract] [Full Text] [Related]

  • 3. Topical mitomycin C application is effective in management of localized caustic esophageal stricture: a double-blinded, randomized, placebo-controlled trial.
    El-Asmar KM, Hassan MA, Abdelkader HM, Hamza AF.
    J Pediatr Surg; 2013 Jul; 48(7):1621-7. PubMed ID: 23895984
    [Abstract] [Full Text] [Related]

  • 4. Topical mitomycin C versus intralesional triamcinolone in the management of esophageal stricture due to caustic ingestion.
    Méndez-Nieto CM, Zarate-Mondragón F, Ramírez-Mayans J, Flores-Flores M.
    Rev Gastroenterol Mex; 2015 Jul; 80(4):248-54. PubMed ID: 26455483
    [Abstract] [Full Text] [Related]

  • 5. Topical Mitomycin C application for esophageal stricture: safe, precise, and novel endoscopic technique.
    El-Asmar KM.
    J Pediatr Surg; 2013 Jun; 48(6):1454-7. PubMed ID: 23845649
    [Abstract] [Full Text] [Related]

  • 6. Mitomycin C: an alternative conservative treatment for refractory esophageal stricture in children?
    Uhlen S, Fayoux P, Vachin F, Guimber D, Gottrand F, Turck D, Michaud L.
    Endoscopy; 2006 Apr; 38(4):404-7. PubMed ID: 16586239
    [Abstract] [Full Text] [Related]

  • 7. Topical Mitomycin C Application in Pediatric Patients with Recurrent Esophageal Strictures-Report on Unfavorable Results.
    Madadi-Sanjani O, Zimmer J, Gosemann JH, Ure BM, Lacher M, Boehm R.
    Eur J Pediatr Surg; 2018 Dec; 28(6):539-546. PubMed ID: 29270948
    [Abstract] [Full Text] [Related]

  • 8. Mitomycin C in the management of pediatric caustic esophageal strictures: a case report.
    Olutoye OO, Shulman RJ, Cotton RT.
    J Pediatr Surg; 2006 May; 41(5):e1-3. PubMed ID: 16677867
    [Abstract] [Full Text] [Related]

  • 9. Topical Mitomycin C Application Is Effective Even in Esophageal Strictures Resistant to Dilatation Therapy in Children.
    Divarci E, Kilic O, Dokumcu Z, Ozcan C, Erdener A.
    Surg Laparosc Endosc Percutan Tech; 2017 Oct; 27(5):e96-e100. PubMed ID: 28902039
    [Abstract] [Full Text] [Related]

  • 10. Predictors of successful endoscopic management of caustic esophageal strictures in children: When to stop the dilatations?
    El-Asmar KM, Allam AM.
    J Pediatr Surg; 2021 Sep; 56(9):1596-1599. PubMed ID: 32943196
    [Abstract] [Full Text] [Related]

  • 11. [Topical mitomycin C treatment of a benign oesophageal stricture following caustic ingestion in a four-year-old boy].
    Fröhlich T, Greess H, Köhler H.
    Z Gastroenterol; 2007 Mar; 45(3):255-8. PubMed ID: 17357956
    [Abstract] [Full Text] [Related]

  • 12. A prospective controlled study to assess the use of mitomycin C in improving the results of esophageal dilatation in post corrosive esophageal stricture in children.
    Sweed AS, Fawaz SA, Ezzat WF, Sabri SM.
    Int J Pediatr Otorhinolaryngol; 2015 Jan; 79(1):23-5. PubMed ID: 25465445
    [Abstract] [Full Text] [Related]

  • 13. Aggressive bougie dilatation and intralesional steroids is effective in refractory benign esophageal strictures secondary to corrosive ingestion.
    Nijhawan S, Udawat HP, Nagar P.
    Dis Esophagus; 2016 Nov; 29(8):1027-1031. PubMed ID: 26542391
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Therapy of caustic ingestion: new treatment considerations.
    Shub MD.
    Curr Opin Pediatr; 2015 Oct; 27(5):609-13. PubMed ID: 26196260
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Topical Mitomycin C application in the treatment of refractory benign esophageal strictures in adults and comprehensive literature review.
    Bartel MJ, Seeger K, Jeffers K, Clayton D, Wallace MB, Raimondo M, Woodward TA.
    Dig Liver Dis; 2016 Sep; 48(9):1058-65. PubMed ID: 27443493
    [Abstract] [Full Text] [Related]

  • 18. Risk factors associated with refractoriness to esophageal dilatation for benign dysphagia.
    Rodrigues-Pinto E, Pereira P, Ribeiro A, Lopes S, Moutinho-Ribeiro P, Silva M, Peixoto A, Gaspar R, Macedo G.
    Eur J Gastroenterol Hepatol; 2016 Jun; 28(6):684-8. PubMed ID: 26849463
    [Abstract] [Full Text] [Related]

  • 19. Fluoroscopic balloon dilatation for caustic esophageal stricture in children: an 8-year experience.
    Uygun I, Arslan MS, Aydogdu B, Okur MH, Otcu S.
    J Pediatr Surg; 2013 Nov; 48(11):2230-4. PubMed ID: 24210191
    [Abstract] [Full Text] [Related]

  • 20. Mitomycin C decreases the rate of stricture formation in caustic esophageal burns in rats.
    Türkyilmaz Z, Sönmez K, Karabulut R, Gülbahar O, Poyraz A, Sancak B, Başaklar AC.
    Surgery; 2009 Feb; 145(2):219-25. PubMed ID: 19167978
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.